Contacts
Ross McNaughton

Ross McNaughton

Partner

Read More
Oli Denne

Oli Denne

Senior Associate

Read More
Contacts
Ross McNaughton

Ross McNaughton

Partner

Read More
Oli Denne

Oli Denne

Senior Associate

Read More

20 March 2024

Advising on Mission Zero Technologies on its £21.8 million Series A funding

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Explaining strategy
Corporate/M&A & capital markets

Nuclera raises additional capital for eProtein™ desktop bioprinter to close Series B funding at $58 million

14 July 2022

by multiple authors

Click here to find out more
White microscope on yellow background
Corporate/M&A & capital markets

Advising New Science Ventures as lead investor on Paragraf's $60 million Series B funding round

4 March 2022

by Ross McNaughton and Adrian Toutoungi

Click here to find out more
Cyan lights fibre optic cable
Life sciences & healthcare

Advising Nuclera on its Series B funding round

2 February 2022

by multiple authors

Click here to find out more